Mexico Founded in 1943, Mexican drugmaker Silanes has built a strong presence across multiple therapeutic areas, namely diabetes and cardiovascular, while expanding into others. The company’s director of pharma and biologics, Rafael Quintanilla, explains Silanes’ journey from being purely a branded generics manufacturer to embracing R&D, which has brought substantial growth…
See our Cookie Privacy Policy Here
